A Northeast Ohio practitioner says this choice comes up first in most visits, noting tirzepatide acts on both GLP-1 and GIP receptors.
Recap by typeshit. Post by Facebook on Facebook.
A Facebook share says Danish teams found certain bacterial strains may change how the gut tells the brain it is full. The work so far is in animal models only.
Bikman calls the results remarkable, but he argues that bigger drops make it more important to know how much of the lost weight is fat and how much is muscle.
Bikman points out that weight usually returns once the drug is stopped, which makes the question of lifelong use a real one.
Avi Roy flags a preprint that pooled 10,052 people from five semaglutide trials and used a blood test to estimate heart age. It has not yet been peer reviewed.
A consumer guide to peptides and the attention around them, for anyone trying to sort the basics from the buzz.
The share puts GLP-1 or dual GIP/GLP-1 use at about 6% of UK adults and roughly 11% of US adults, with restaurants adjusting what they serve.
Loading…